306 related articles for article (PubMed ID: 17890862)
1. Long-term safety and efficacy of ivabradine in patients with chronic stable angina.
López-Bescós L; Filipova S; Martos R
Cardiology; 2007; 108(4):387-96. PubMed ID: 17890862
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus.
Borer JS; Tardif JC
Am J Cardiol; 2010 Jan; 105(1):29-35. PubMed ID: 20102886
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectoris.
Tendera M; Borer JS; Tardif JC
Cardiology; 2009; 114(2):116-25. PubMed ID: 19468225
[TBL] [Abstract][Full Text] [Related]
4. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.
Picano E;
Eur Heart J; 2001 Oct; 22(19):1785-93. PubMed ID: 11549300
[TBL] [Abstract][Full Text] [Related]
5. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
[TBL] [Abstract][Full Text] [Related]
6. Treatment of stable angina pectoris by ivabradine in every day practice: the REDUCTION study.
Köster R; Kaehler J; Meinertz T;
Am Heart J; 2009 Oct; 158(4):e51-7. PubMed ID: 19781403
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study.
Fox K; Ferrari R; Tendera M; Steg PG; Ford I;
Am Heart J; 2006 Nov; 152(5):860-6. PubMed ID: 17070146
[TBL] [Abstract][Full Text] [Related]
8. Impact of a pure reduction in heart rate for the treatment of left ventricular dysfunction: clinical benefits of ivabradine in the BEAUTIFUL trial.
Danchin N
Therapie; 2009; 64(2):111-4. PubMed ID: 19664404
[TBL] [Abstract][Full Text] [Related]
9. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Ruzyllo W; Tendera M; Ford I; Fox KM
Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
[TBL] [Abstract][Full Text] [Related]
10. Ivabradine: beyond heart rate control.
Riccioni G; Vitulano N; D'Orazio N
Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
Borer JS; Le Heuzey JY
Am J Ther; 2008; 15(5):461-73. PubMed ID: 18806523
[TBL] [Abstract][Full Text] [Related]
12. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.
Fox K; Ford I; Steg PG; Tendera M; Robertson M; Ferrari R;
Eur Heart J; 2009 Oct; 30(19):2337-45. PubMed ID: 19720635
[TBL] [Abstract][Full Text] [Related]
13. Ivabradine: new drug. Best avoided in stable angina.
Prescrire Int; 2007 Apr; 16(88):53-6. PubMed ID: 17458043
[TBL] [Abstract][Full Text] [Related]
14. Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina.
Prasad UK; Gray D; Purcell H
Adv Ther; 2009 Feb; 26(2):127-37. PubMed ID: 19259630
[TBL] [Abstract][Full Text] [Related]
15. Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.
Tardif JC; Ponikowski P; Kahan T;
Int J Cardiol; 2013 Sep; 168(2):789-94. PubMed ID: 23138014
[TBL] [Abstract][Full Text] [Related]
16. Focus on ivabradine: a new heart rate-controlling drug.
Riccioni G
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):107-13. PubMed ID: 19210206
[TBL] [Abstract][Full Text] [Related]
17. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
Müller-Werdan U; Stöckl G; Ebelt H; Nuding S; Höpfner F; Werdan K;
Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
[TBL] [Abstract][Full Text] [Related]
18. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
Doesch AO; Celik S; Ehlermann P; Frankenstein L; Zehelein J; Koch A; Katus HA; Dengler TJ
Transplantation; 2007 Oct; 84(8):988-96. PubMed ID: 17989604
[TBL] [Abstract][Full Text] [Related]
19. Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.
Sulfi S; Timmis AD
Int J Clin Pract; 2006 Feb; 60(2):222-8. PubMed ID: 16451297
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE).
Koren MJ; Crager MR; Sweeney M
J Am Coll Cardiol; 2007 Mar; 49(10):1027-34. PubMed ID: 17349881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
